Zhangjin Shen

Sir Run Run Shaw Hospital
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Erratum: Effects of lysate/tissue storage at -80°C on subsequently extracted EVs of epithelial ovarian cancer tissue origins.

Erratum: Effects of lysate/tissue storage at -80°C on subsequently extracted EVs of epithelial ovarian cancer tissue origins.

Journal: iScience

Published: February 13, 2026

COL1A1-induced LOXL2 promotes ovarian cancer metastasis via a feedback loop upon inhibiting EGFR lysosomal degradation.

COL1A1-induced LOXL2 promotes ovarian cancer metastasis via a feedback loop upon inhibiting EGFR lysosomal degradation.

Journal: Experimental & molecular medicine

Published: April 01, 2025

The INAVA mRNA in Extracellular Vesicles Activates Normal Ovarian Fibroblasts by Phosphorylation-Ubiquitylation Crosstalk of HMGA2.

The INAVA mRNA in Extracellular Vesicles Activates Normal Ovarian Fibroblasts by Phosphorylation-Ubiquitylation Crosstalk of HMGA2.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: January 15, 2025

RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer through upregulation of RAD51B.

RAD51B-AS1 promotes the malignant biological behavior of ovarian cancer through upregulation of RAD51B.

Journal: Journal of Zhejiang University. Science. B

Published: July 16, 2024

PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.

PINK1-PTEN axis promotes metastasis and chemoresistance in ovarian cancer via non-canonical pathway.

Journal: Journal of experimental & clinical cancer research : CR

Published: July 06, 2023

CircSLC39A8 attenuates paclitaxel resistance in ovarian cancer by regulating the miR‑185‑5p/BMF axis.

CircSLC39A8 attenuates paclitaxel resistance in ovarian cancer by regulating the miR‑185‑5p/BMF axis.

Journal: Translational oncology

Published: April 13, 2023

MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage.

MAP4K4 promotes ovarian cancer metastasis through diminishing ADAM10-dependent N-cadherin cleavage.

Journal: Oncogene

Published: October 14, 2022

Effects of lysate/tissue storage at -80°C on subsequently extracted EVs of epithelial ovarian cancer tissue origins.

Effects of lysate/tissue storage at -80°C on subsequently extracted EVs of epithelial ovarian cancer tissue origins.

Journal: iScience

Published: October 14, 2022

Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis.

Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis.

Journal: Frontiers in pharmacology

Published: August 09, 2022

Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer.

Olaparib synergizes with arsenic trioxide by promoting apoptosis and ferroptosis in platinum-resistant ovarian cancer.

Journal: Cell death & disease

Published: April 25, 2022

PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA.

PLAA suppresses ovarian cancer metastasis via METTL3-mediated m6A modification of TRPC3 mRNA.

Journal: Oncogene

Published: April 04, 2022

Distinct Roles of m5C RNA Methyltransferase NSUN2 in Major Gynecologic Cancers.

Distinct Roles of m5C RNA Methyltransferase NSUN2 in Major Gynecologic Cancers.

Journal: Frontiers in oncology

Published: September 30, 2021

Showing 1-12 of 13

Last Updated: 09/26/2026